27 November 2020 – New study estimates lethality of COVID-19

Type of Intervention: Specific Action
Sectors Involved: Health
Level of Jurisdiction: National
Lead People/Agency: Ministry of Health and the National Epidemiology Center of the Carlos III Health Institute (ISCIII)

Overview: A study estimates the lethality of SARS-CoV-2 infection in non-institutionalized population in Spain
Overview:
A study led by researchers from the National Epidemiology Center of the Carlos III Health Institute (ISCIII) and published in the British Medical Journal estimates that the lethality of SARS-CoV-2 infection in non-institutionalized population in Spain is situated between 0.8% and 1.1%.
The work, carried out from the data provided by the ENE-COVID National Seroepidemiology Study, the National Epidemiological Surveillance Network (RENAVE) and the Daily Mortality Monitoring System (MoMo), estimates the lethality of the infection. The increase in SARS-CoV-2 infection fatality risk for those aged above 50 appeared to be more noticeable in men than in women. Based on the results of this study, fatality from covid-19 was higher than that reported for other common respiratory diseases, such as seasonal influenza.

Full details here: http://www.bmj.com/content/bmj/371/bmj.m4509.full.pdf

Type of Justification: Advice of INTERNAL government advisory committee or group, Scientific Evidence (e.g. academic paper, report)
Source of Evidence or Justification: National – academic, International – academic